11.8% Below Target

Incyte Corporation (INCY) has a consensus 12-month price target of $109.8, implying 11.8% upside from $98.22. The 44 analysts covering INCY see moderate appreciation potential.

INCY has a consensus rating of "Buy" based on 44 Wall Street analysts. The rating breakdown is predominantly bullish, with 23 Buy/Strong Buy ratings. The consensus 12-month price target of $109.8 implies 11.8% upside from current levels.

With a forward P/E of 13.0426x, INCY trades at a relatively low valuation. The consensus target of $109.8 implies 11.8% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $140 for INCY, while the most conservative target is $90. The consensus of $109.8 represents the median expectation. Our quantitative valuation model projects a bull case target of $183 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

INCY is heavily covered by Wall Street, with 44 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 23 have Buy ratings, 19 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month INCY stock forecast based on 44 Wall Street analysts shows a consensus price target of $109.8, with estimates ranging from $90 (bear case) to $140 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $139, with bear/bull scenarios of $87/$183.

Our quantitative valuation model calculates INCY's fair value at $139 (base case), with a bear case of $87 and bull case of $183. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

INCY trades at a forward P/E ratio of 13.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on INCY, with a "Buy" consensus rating and $109.8 price target (11.8% upside). 23 of 44 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

INCY analyst price targets range from $90 to $140, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $109.8 consensus represents the middle ground. Our model's $87-$183 range provides an independent fundamental perspective.